|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.85 SAR | -1.08% |
|
-0.27% | -3.32% |
| 11-18 | Kepler Cheuvreux Reduces Nahdi Medical's PT, Affirms Buy Rating | MT |
| 11-03 | HSBC Trims Nahdi Medical PT, Affirms Buy Rating | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NAHDI MEDICAL COMPANY | Other Drug Retailers | -1.08% | -0.27% | -3.32% | -22.29% | - | 3.18B |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- 4164 Stock
- Charts Nahdi Medical Company
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition